HEALEY ALS Trial: Pridopidine Shows No Impact on Disease Progression in ALS Medha Baranwal17 April 2025 8:15 PM ISTUSA: A recent study evaluating pridopidine for treating amyotrophic lateral sclerosis (ALS) has found no significant effect on disease progression....
Zydus Usnoflast gets USFDA Orphan Drug Designation for amyotrophic lateral sclerosis Ruchika Sharma23 Jan 2025 1:15 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that the U.S. Food and Drug Administration (USFDA) has granted...
Zydus Lifesciences gets USFDA nod to conduct Phase II(b) clinical trial for Usnoflast for Amyotrophic Lateral Sclerosis Ruchika Sharma19 Jan 2025 2:45 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company has announced that it has received approval from USFDA to conduct Phase...
Zydus Lifesciences completes Phase II(a) clinical trial of Usnoflast in patients with Amyotrophic Lateral Sclerosis Ruchika Sharma11 Sept 2024 12:30 PM ISTAhmedabad: Zydus, a discovery-based, global pharmaceutical company, announced the completion of its Phase II(a) clinical study of NLRP3...
ALS diagnosis and survival linked to metals in blood, urine, suggests research Dr. Kamal Kant Kohli16 Aug 2024 10:30 PM ISTPeople with higher levels of metals found in their blood and urine may be more likely to be diagnosed with-and die from-amyotrophic lateral sclerosis,...
Gland Pharma bags USFDA nod for amyotrophic lateral sclerosis injection Edaravone Ruchika Sharma8 May 2024 11:30 AM ISTThe Product is used to treat amyotrophic lateral sclerosis.
Zydus Lifesciences bags USFDA tentative nod for Edaravone Injection to treat amyotrophic lateral sclerosis Susmita Roy15 March 2024 11:49 AM ISTEdaravone is used to treat a certain type of nerve disease called amyotrophic lateral sclerosis.
EU medicines regulator backs Biogen ALS drug Ruchika Sharma25 Feb 2024 11:30 AM ISTCambridge: Biogen Inc. has announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a...
Dr Reddys Labs arm, Coya Therapeutics ink pact for Amyotrophic Lateral Sclerosis therapy COYA 302 Ruchika Sharma7 Dec 2023 1:30 PM ISTDr Reddy's will make a USD 7.5 million upfront payment to Coya.
Dietary Choices May Impact Amyotrophic Lateral Sclerosis Progression Dr.Niharika Harsha B27 Nov 2023 9:45 AM ISTIn a groundbreaking investigation, researchers have uncovered a potential connection between dietary choices and the progression of amyotrophic...
Ravulizumab lacks treatment effect, highlights unmet need for highly effective treatment for ALS Medha Baranwal18 Nov 2023 9:30 AM ISTUSA: A recent study published in JAMA Neurology investigated the safety and efficacy of ravulizumab, a complement C5 inhibitor, in adults with...
Zydus Lifesciences gets CDSCO nod to begin Phase II clinical trial of ZYIL1 in Amyotrophic Lateral Sclerosis patients Ruchika Sharma25 Oct 2023 11:16 AM ISTThe Phase II clinical trial will study safety, tolerability, pharmacokinetics and pharmacodynamics in patients with ALS.
